Concerns Mounting Over Stroke Medication
Experts worry that the drug may increase the chances of brain bleeds occurring in stroke victims.
MHRA Reviewing Alteplase
The United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) has been asked to re-examine the safety of the drug after claims of the previous assessment suffering from flaws.
Stroke victims are often prescribed Alteplase to dissipate clots in a treatment known as thrombolysis. It may lead to an increased risk of bleeding in the brain, but previous evidence supporting the drug suggested the danger was outweighed by the benefits of improvements overall for the stroke victim.
The MHRA recently reaffirmed that the benefits outweighed the risk but also reports it intends to follow-up concerns with a thorough investigation into the safety of the drug. The MHRA is expected to report back sometime in 2015 with the results of their investigation.
The German manufacturer, Boehringer Ingelheim, released a statement supporting Alteplase as a safe drug for consumers.
Information provided by U.S. Centers for Disease Control and Prevention (CDC).
- Stroke is the leading cause of death in the U.S.
- 1 in 19 Americans die annually from stroke.
- One person has a stroke every 4 minutes in the U.S.
- 795,000 people suffer from a stroke in the U.S every year.